Actinomycesin AMSIN, Defensin-like Bacteriocin
General Information
DCTPep ID DCTPep04356
Peptide Name Actinomycesin AMSIN, Defensin-like Bacteriocin
Sequence GFGCPWNAYECDRHCVSKGYTGGNCRGKIRQTCHCY
Sequence Length 36
UniProt ID E7N5J9
PubChem CID Not available
Origin Bacteria
Type Native peptide
Classification
Cancer therapy related peptides
Activity Information
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Structure Information
PDB ID 2RU0
Predicted Structure Not available
(Please note that there is the predicted structure, predicted by AlphaFold)
Helicity Not available
Linear/Cyclic Cyclic
Disulfide/Other Bond Cys4<--->Cys25; Cys11<--->Cys33; Cys15<--->Cys35
N-terminal Modification Free
C-terminal Modification Free
Other Modification None
Chiral L
Physicochemical Information
Formula C171H253N55O50S6
Absent amino acids LM
Theoretical pI 8.65
Acidic residues 2
Basic residues 7
Polar residues 20
Molecular weight (Average) 4071.59
Molecular weight (Monoisotopic) 4068.73
Common amino acids CG
Net charge 5
Instability index (II) 32.49
Aliphatic index 21.67
Grand average of hydropathicity (GRAVY) -0.775
Half Life
30 hours (mammalian reticulocytes, in vitro).
>20 hours (yeast, in vivo).
>10 hours (Escherichia coli, in vivo).
Extinction coefficients
Ext. coefficient 10345
Abs 0.1% (=1 g/l) 2.541, assuming all pairs of Cys residues form cystines
Ext. coefficient 9970
Abs 0.1% (=1 g/l) 2.449, assuming all Cys residues are reduced
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 34927385
Title Adaptively evolved human oral actinomyces-sourced defensins show therapeutic potential
Doi Not available
Year 2022
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
External Code
DBAASP ID 19007